Company profile
Enovis Corporation
NYSE: ENOV · Healthcare · Medical - Devices
#107 of 1,418 Healthcare companies by revenue51st-percentile growth
EA Score
66BFH 55DQ 87GM 49SS 83
v0.1 · 65/100 weight · provisional
↑ workforce scale, disclosure history · ↓ growth stability, return on equity
Methodology →Revenue TTM
$2.3B
Rev growth YoY (TTM)
+6.0%
Net income (FY)
-$1.2B
Employees
7,802
as of 2026-08-10
Market cap
$1.5B
as of 2026-08-10
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$2.2B$2.2B2025
Net income-$1.2B-$1.2B2025
Operating income-$1.1B-$1.1B2025
Total assets$3.8B$3.8B2025
Liabilities$2.3B$2.3B2025
Equity$1.5B$1.5B2025
Revenue trend
FY2021 – FY2025 · USD
FY21
FY22
FY22
FY22
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Enovis Corporation’s revenue?
Enovis Corporation booked $2.2B in FY2025 revenue, growing 6.7% year over year — about the middle of the pack among Healthcare companies we track, at a -52.7% net margin.
Peers · Healthcare
Hims & Hers Health, Inc.68BExelixis, Inc.89ANatera, Inc.75B+ICU Medical, Inc.78B+Concentra Group Holdings Parent, Inc.68BPrivia Health Group, Inc.68BNeighbors
New Castle →Key facts
CEODamien McDonald
SectorHealthcare
IndustryMedical - Devices
HeadquartersWilmington, DE
ExchangeNYSE: ENOV
Employees7,802
IPO date2008-05-08
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.